Home › Funds › RICE HALL JAMES & ASSOCIATES, LLC › MEDP

RICE HALL JAMES & ASSOCIATES, LLC position in MEDP

MEDPACE HLDGS INC · Health Care

RICE HALL JAMES & ASSOCIATES, LLC reported holding 52,852 shares of MEDP (MEDPACE HLDGS INC) in its Q3 2026 13F filing — a position valued at US$33.0M, representing 1.75% of its reported portfolio and ranking #13 among its reported holdings. RICE HALL JAMES & ASSOCIATES, LLC has disclosed MEDP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)52.85K sh
Reported value held$32.99M
Portfolio Weight1.75%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How RICE HALL JAMES & ASSOCIATES, LLC's MEDP position evolved

RICE HALL JAMES & ASSOCIATES, LLC first disclosed a stake in MEDP in Q3 2023 at 132,087 shares (US$32.0M). The position peaked in Q1 2024 at 121,885 shares, worth US$49.3M. Across 13 filings, RICE HALL JAMES & ASSOCIATES, LLC increased the stake 0 time(s), trimmed it 11 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 52,852 shares valued at US$33.0M — a reduction of -1,264 shares quarter over quarter.. Notable position changes include a 32% trim in Q4 2025 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 132.09K $31.98M New
Q4 2023 127.64K $39.13M Reduce
Q1 2024 121.89K $49.26M Reduce
Q2 2024 113.49K $46.74M Reduce
Q3 2024 109.80K $36.65M Reduce
Q4 2024 104.48K $34.71M Reduce
Q1 2025 103.13K $31.42M Reduce
Q2 2025 102.45K $32.16M Reduce
Q3 2025 91.41K $47.00M Reduce
Q4 2025 62.51K $35.11M Reduce
Q1 2026 53.98K $25.92M Reduce
Q2 2026 54.12K $28.66M Hold
Q3 2026 52.85K $32.99M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MEDP and 13F data

MEDP (MEDPACE HLDGS INC) is a Health Care company. 43 other funds we track also report a position in MEDP — the largest reported positions include WASATCH ADVISORS LP (US$290.8M), Renaissance Technologies (US$282.4M), Giverny Capital Inc. (US$152.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MEDP

All MEDP fund holders →

FAQ

How long has RICE HALL JAMES & ASSOCIATES, LLC held MEDP?

RICE HALL JAMES & ASSOCIATES, LLC has disclosed MEDP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is RICE HALL JAMES & ASSOCIATES, LLC's current position in MEDP?

As of Q3 2026, RICE HALL JAMES & ASSOCIATES, LLC holds 52.85K shares of MEDP (MEDPACE HLDGS INC), valued at $32.99M, representing 1.75% of its reported portfolio and ranking #13.

Has RICE HALL JAMES & ASSOCIATES, LLC been buying or selling MEDP?

In the latest 13F filing (Q3 2026), RICE HALL JAMES & ASSOCIATES, LLC reduced its position in MEDP. The position peaked in Q1 2024 at 121.89K shares.

Which other funds hold MEDP?

Other major institutional holders of MEDP include WASATCH ADVISORS LP, Renaissance Technologies, Giverny Capital Inc., among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.